Among the analytes measured, concentrations of IL-12p40, IFN-γ and TNF-α in PBMC culture supernatant from TB-IRIS patients significantly decreased following treatment with MyD88 inhibitor, but not with the control peptide, compared with the RPMI mock (Fig. 6). The gene discussed is MYD88; the disease is tuberculosis.